Gilead Sciences (GILD) Tops Q1 EPS by 15c, Reiterate Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. MRVL
2. ZS
3. PENG
4. NVDA
5. STZ
6. MSFT
7. SPY
8. SKYD
9. CRWV
10. RCKT

Go back to Gilead Sciences (GILD) Tops Q1 EPS by 15c, Reiterate Guidance

Gilead Sciences Announces First Quarter 2019 Financial Results

May 2, 2019 4:01 PM EDT

- Product Sales of $5.2 billion -
- Diluted EPS of $1.54 per share -
- Non-GAAP Diluted EPS of $1.76 per share -
- Reiterates Full Year 2019 Guidance -

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the first quarter ended March 31, 2019. The financial results that follow represent a year-over-year comparison of the first quarter 2019 to the first quarter 2018. Total revenues were $5.3 billion in 2019 compared to $5.1 billion in 2018. Net income was $2.0 billion or... More